Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin digestion is a critical biochemical process for blood-feeding parasites such as ticks and Plasmodium (the causative agent of malaria), enabling them to extract essential nutrients from host hemoglobin. This catabolic process is driven by a coordinated cascade of intracellular proteases, including aspartic, cysteine, and metalloproteases, which break down hemoglobin at acidic pH, commonly found within digestive vacuoles. Inhibiting these proteases blocks parasite development, making them validated therapeutic targets for antimalarial and anti-tick strategies. However, "hemoglobin digestion" does not refer to a single molecule or receptor, but rather a process governed by several enzymes that should be considered individually as molecular targets.
Inhibition of hemoglobin-digesting proteases prevents parasites from metabolizing host hemoglobin, starving them of nutrients and halting development
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin-digesting protease cascade.